John De Vos
banner
jdevos.bsky.social
John De Vos
@jdevos.bsky.social

#StemCells Researcher | Director of the Cell Processing Facility
University of Montpellier - CHU of Montpellier | #StemCells #iPScells for #lung #CellTherapy |
Stem Genomics co-founder | President of the FSSCR

Biology 37%
Environmental science 10%

A phase II trial using #CART cells against a solid tumor (glioblastoma).
T-MAXIMUM Pharmaceutical announced that its proprietary allogeneic B7-H3–targeted CAR-T therapy, MT027, has received FDA IND clearance.
buff.ly/wiGPeyR

Reposted by John De Vos

Modeling human embryo implantation in vitro: building a receptive endometrium and its interaction with blastoids (“synthetic embryos”). A remarkable achievement!
buff.ly/eZtS5NG
www.cell.com

Reposted by John De Vos

Reposted by John De Vos

Reposted by John De Vos

Reposted by John De Vos

Kyverna to take autoimmune CAR-T to FDA after success in stiff person syndrome trial.
#CARTCells #Autoimmune disease
Kyverna to take autoimmune CAR-T to FDA after success in stiff person syndrome trial
Kyverna Therapeutics' CAR-T therapy succeeded in a key study in stiff person syndrome, a rare autoimmune disorder that leads to painful muscle spasms and stiffness.
buff.ly

Reposted by John De Vos

Reposted by John De Vos

Le samedi soir, il est réjouissant – voire emballant – de poster du Tom Gauld www.tomgauld.com (description et traduction en cliquant sur ALT).
Holy crap!!

Reposted by John De Vos

Reposted by John De Vos

Reposted by John De Vos

En ce mois de décembre, laissez vous guider par la magie du Jardin des Plantes de Montpellier : un écrin de nature à découvrir au fil de nos visites....

Allogeneic anti-CD7 #CARTCells for relapsing T-ALL eradication prior to hematopoietic allograft!

Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia | New England Journal of Medicine buff.ly/7jYX07o
Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia | NEJM
CD7 is an attractive target for chimeric antigen receptor (CAR) T-cell therapy in relapsed or refractory T-cell acute lymphoblastic leukemia (ALL). Supportive results of first-in-human studies of b...
www.nejm.org

Reposted by John De Vos

Reposted by John De Vos

Venez découvrir en ce mois de décembre la serre à cactées du Jardin des Plantes de MONTPELLIER.
Attention, vous devez vous inscrire pour y participer.

Reposted by John De Vos

Reposted by John De Vos

Reposted by John De Vos

Reposted by John De Vos

Reposted by John De Vos

Reposted by John De Vos

Reposted by John De Vos